This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-preview: Archive
Will Green Plains Renewable Energy (GPRE) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Green Plains (GPRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GPRENegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Esperion Therapeutics (ESPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ESPRNegative Net Change BCRXNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Will EVgo Inc. (EVGO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
EVgo (EVGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EVGOPositive Net Change BWANegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Expeditors International (EXPD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Expeditors International (EXPD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXPDNegative Net Change HUBGNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Shift4 Payments (FOUR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Shift4 Payments (FOUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FOURPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CYRXNegative Net Change SNDRNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Evolus, Inc. (EOLS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Evolus (EOLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EOLSPositive Net Change RMDPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Euroseas Ltd. (ESEA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Euroseas (ESEA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ESEAPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Countdown to Colgate-Palmolive (CL) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Colgate-Palmolive (CL) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CLPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ahead of Imperial Oil (IMO) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Imperial Oil (IMO) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
IMOPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unveiling W.W. Grainger (GWW) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for W.W. Grainger (GWW), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
GWWNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Gear Up for CBOE (CBOE) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for CBOE (CBOE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
CBOEPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unveiling Tyler Technologies (TYL) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Tyler Technologies (TYL) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
TYLNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exxon (XOM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Evaluate the expected performance of Exxon (XOM) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
XOMNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Curious about International Paper (IP) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of International Paper (IP) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
IPNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Cenovus (CVE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Cenovus (CVE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
CVENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Countdown to Mettler-Toledo (MTD) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Mettler-Toledo (MTD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
MTDNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With Ares Management (ARES) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Ares Management (ARES), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
ARESNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Linde (LIN) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Linde (LIN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
LINPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Insights Into T. Rowe (TROW) Q2: Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for T. Rowe (TROW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
TROWNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q2 Potential of Oshkosh (OSK): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Oshkosh (OSK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
OSKNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ahead of PTC Inc. (PTC) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for PTC Inc. (PTC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
PTCNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ahead of Ventas (VTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Ventas (VTR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
VTRPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Gear Up for Dominion Energy (D) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Dominion Energy (D), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
DNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Curious about Moderna (MRNA) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Moderna (MRNA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
MRNAPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview